Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Infantile Spasms
100%
New Therapies
100%
Spasm
100%
Adrenocorticotropic Hormone
33%
Seizure
33%
Cognitive Deficits
22%
Vigabatrin
22%
Acute Efficacy
22%
Dose-response Experiments
22%
Rapamycin
22%
Rapid Onset
22%
Disease-modifying Therapy
22%
Clinical Screening
22%
Screening Tool
22%
Time Response
22%
Neonatal Reflexes
11%
Single Drug
11%
Electroclinical Features
11%
Sustained Efficacy
11%
Multi-hit Model
11%
Preclinical Testing
11%
Poor Prognosis
11%
Duration of Effect
11%
Hormone Refractory
11%
Infusion Monitoring
11%
Cognitive Outcome
11%
IND Application
11%
Development Testing
11%
Carisbamate
11%
Disease-modifying Effect
11%
Drug Infusion
11%
Sustained Effect
11%
Screening Algorithm
11%
Learning Effect
11%
Cognitive Ability
11%
Epileptic Seizure
11%
Medically Refractory
11%
Specific Expression
11%
Effective Compounds
11%
Comorbidity
11%
Preclinical Development
11%
Current Therapies
11%
Drug Injection
11%
Age-specific
11%
Epileptic Encephalopathy
11%
Seizure Type
11%
Drug-resistant Epilepsy
11%
Antiepileptogenic
11%
Medicine and Dentistry
Muscle Spasm
100%
Infantile Spasm
100%
Epileptic Seizure
44%
Diseases
33%
Corticotropin
33%
Vigabatrin
22%
Dose Response
22%
Rapamycin
22%
Cognitive Defect
22%
Pulse Rate
11%
Long-Term Outcome
11%
Cognitive Function
11%
Carisbamate
11%
Drug Resistant Epilepsy
11%
Brain Disease
11%
Comorbidity
11%
Infancy
11%
Drug Screening
11%
Drug Administration
11%
Side Effect
11%
Seizure Types
11%
Drug Infusion
11%
Pharmacology, Toxicology and Pharmaceutical Science
Muscle Spasm
100%
Infantile Spasm
100%
Corticotropin
33%
Diseases
33%
Rapamycin
22%
Vigabatrin
22%
Cognitive Defect
22%
Drug Screening
11%
Drug Resistant Epilepsy
11%
Carisbamate
11%
Syndrome
11%
Drug Development
11%
Brain Disease
11%
Comorbidity
11%
Side Effect
11%
Rat
11%